John Lo

John Lo, Ph.D., is chief commercial officer of Beam, where he is responsible for commercial readiness as well as leading product and portfolio strategy of a rapidly maturing and expanding portfolio. Dr. Lo joins Beam after serving as an advisor to multiple private and public stage biotechnology companies including Beam. Dr. Lo has held a number of global strategic and operating roles of increasing responsibility within the biopharmaceutical industry, as senior vice president, worldwide hematology at Bristol Myers Squibb, head of global marketing and market access at Astra Zeneca, corporate vice president, hematology and oncology at Celgene, and multiple P&L roles at Novartis. While at these companies, Dr. Lo has successfully launched numerous drugs in the US and globally, including Tagrisso in lung cancer and two cell therapies. Dr. Lo has also helped build strategies and grow R&D pipelines as co-chair of the Development Committee at Celgene, leading to multiple pivotal study investments. Dr. Lo also spent several years as an associate principal at McKinsey & Company and holds a Ph.D. in molecular biology from MIT.